Medically reviewed by Femi Aremu, PharmD Ozempic and Wegovy are both glucagon-like peptide-1 (GLP-1) receptor agonists and contain the active ingredient semaglutide. They share many similarities, and both effectively lower cardiovascular risk.

Obesity is a global pandemic. According to the World Health Organization (WHO), adult obesity in the world more than doubled between 1990 and 2022. This has led to more health problems ranging from cardiovascular diseases,

WeightWatchers is filing for bankruptcy after 62 years since the launch of its revolutionary dieting program. The company announced it had entered Chapter 11 protection on Tuesday to “eliminate $1.15 billion in debt.